Goldman Sachs Increases PT On Cigna Corporation To 60$, Maintains Buy (CI)

Goldman Sachs increased its price target on Cigna Corporation CI from $56 to $60. In a research report published today, Goldman named better than expected Q1 earnings results, which also led to an upgrade in Goldman's EPS estimate, as a reason for increasing its price target on Cigna. In the report, Goldman states, "Following 1Q, we increase 2011/2012/2013 EPS to $5.20/$6.00/$7.00 from $4.80/$5.40/$6.05 and raise our price target to $60, implying over 27% upside." Goldman has also reiterated its Buy rating on Cigna. In yesterday's trading, Cigna's shares added 2.74% to their value to close the day at $47.18. Its shares continued to gain value in today's pre-market trading as well. At the moment, its share are trading at $48.28, an increase of 2.33% on yesterday's value.